Visit https://www.peervoice.com/UBY860 to view the entire programme with slides. After completing “Best Practices in Early-Stage EGFR-Mutant NSCLC: What Surgeons Need to Know”, participants will be able to: Discuss the role of the thoracic surgeon in the management of early-stage EGFR-mutant NSCLC, Explain best practices for resection and adjuvant therapy for patients with early-stage EGFR-mutant NSCLC, Formulate strategies to improve communication and collaboration among the multidisciplinary team.